Bragg Financial Advisors’s GSK GSK Stock Holding History

Bragg Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,812	Closed	-$392K	–	253
2018 Q3	$392K	Hold	7,812	–	–	0.05%	209
2018 Q2	$394K	Hold	7,812	–	–	0.06%	205
2018 Q1	$382K	Hold	7,812	–	–	0.06%	215
2017 Q4	$346K	Buy	7,812 +36	+0.5%	+$1.66K	0.05%	226
2017 Q3	$395K	Sell	7,776 -54	-0.7%	-$2.74K	0.06%	212
2017 Q2	$422K	Hold	7,830	–	–	0.07%	211
2017 Q1	$413K	Hold	7,830	–	–	0.07%	216
2016 Q4	$377K	Hold	7,830	–	–	0.06%	220
2016 Q3	$422K	Buy	7,830 +214	+3%	+$11.7K	0.08%	212
2016 Q2	$413K	Hold	7,616	–	–	0.07%	211
2016 Q1	$386K	Hold	7,616	–	–	0.07%	210
2015 Q4	$384K	Sell	7,616 -172	-2%	-$8.77K	0.08%	199
2015 Q3	$374K	Sell	7,788 -318	-4%	-$16.6K	0.09%	189
2015 Q2	$422K	Buy	8,106 +278	+4%	+$15.7K	0.1%	191
2015 Q1	$452K	Buy	7,828 +172	+2%	+$9.86K	0.1%	187
2014 Q4	$409K	Sell	7,656 -364	-5%	-$20.4K	0.1%	185
2014 Q3	$461K	Hold	8,020	–	–	0.12%	179
2014 Q2	$536K	Hold	8,020	–	–	0.13%	174
2014 Q1	$536K	Hold	8,020	–	–	0.13%	174
2013 Q4	$535K	Hold	8,020	–	–	0.13%	175
2013 Q3	$503K	Hold	8,020	–	–	0.13%	173
2013 Q2	$501K	Buy	+8,020	New	+$509K	0.14%	166

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bragg Financial Advisors's GSK Position: Q4 2018 in Review

Bragg Financial Advisors sold out of GSK (GSK) in Q4 2018, closing a stake of 7,812 shares — an estimated $392K sold.

Bragg Financial Advisors first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $536K in Q2 2014. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Bragg Financial Advisors reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Bragg Financial Advisors sold 7,812 GSK shares in Q4 2018, an estimated $392K.
Bragg Financial Advisors first reported a position in GSK in Q2 2013 and held it in 22 quarters.
Bragg Financial Advisors's GSK position peaked at $536K in Q2 2014.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Bragg Financial Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.